# Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

> **NCT01925417** · PHASE2 · COMPLETED · sponsor: **Rebiotix Inc.** · enrollment: 34 (actual)

## Conditions studied

- Recurrent Clostridium Difficile Infection

## Interventions

- **BIOLOGICAL:** RBX2660 (microbiota suspension)

## Key facts

- **NCT ID:** NCT01925417
- **Lead sponsor:** Rebiotix Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-03
- **Final completion:** 2014-07
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2019-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01925417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01925417, "Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01925417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*